Authors:
Refolo, LM
Pappolla, MA
LaFrancois, J
Malester, B
Schmidt, SD
Thomas-Bryant, T
Tint, GS
Wang, R
Mercken, M
Petanceska, SS
Duff, KE
Citation: Lm. Refolo et al., A cholesterol-lowering drug reduces beta-amyloid pathology in a transgenicmouse model of Alzheimer's disease, NEUROBIOL D, 8(5), 2001, pp. 890-899
Citation: Ac. Andorn et Ma. Pappolla, Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brain, FREE RAD B, 31(3), 2001, pp. 315-320
Citation: Ma. Pappolla, Amyloid deposition in diffuse plaques may or may not start at the neuronalcell surface membrane, J NE EXP NE, 60(1), 2001, pp. 105-105
Authors:
Pappolla, MA
Omar, RA
Chyan, YJ
Ghiso, J
Hsiao, K
Bozner, P
Perry, G
Smith, MA
Cruz-Sanchez, F
Citation: Ma. Pappolla et al., Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a 'foreign body', J NEUROCHEM, 78(1), 2001, pp. 121-128
Authors:
Poeggeler, B
Miravalle, L
Zagorski, MG
Wisniewski, T
Chyan, YJ
Zhang, YB
Shao, HY
Bryant-Thomas, T
Vidal, R
Frangione, B
Ghiso, J
Pappolla, MA
Citation: B. Poeggeler et al., Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A beta peptide, BIOCHEM, 40(49), 2001, pp. 14995-15001
Authors:
Refolo, LM
Malester, B
LaFrancois, J
Bryant-Thomas, T
Wang, R
Tint, GS
Sambamurti, K
Duff, K
Pappolla, MA
Citation: Lm. Refolo et al., A high fat, high cholesterol diet accelerates beta-amyloid accumulation inthe CNS of a transgenic mouse model of Alzheimer's disease, ALZHEIMER'S DISEASE, 2001, pp. 433-447
Authors:
Refolo, LM
Pappolla, MA
Malester, B
LaFrancois, J
Bryant-Thomas, T
Wang, R
Tint, GS
Sambamurti, K
Duff, K
Citation: Lm. Refolo et al., Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model (vol 7, pg 321, 2000), NEUROBIOL D, 7(6), 2000, pp. 690-691
Authors:
Refolo, LM
Pappolla, MA
Malester, B
LaFrancois, J
Bryant-Thomas, T
Wang, R
Tint, GS
Sambamurti, K
Duff, K
Citation: Lm. Refolo et al., Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model, NEUROBIOL D, 7(4), 2000, pp. 321-331
Authors:
Pappolla, MA
Chyan, YJ
Poeggeler, B
Frangione, B
Wilson, G
Ghiso, J
Reiter, RJ
Citation: Ma. Pappolla et al., An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease, J NEURAL TR, 107(2), 2000, pp. 203-231
Authors:
Pappolla, MA
Chyan, YJ
Poeggeler, B
Bozner, P
Ghiso, J
LeDoux, SP
Wilson, GL
Citation: Ma. Pappolla et al., Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: Prevention by melatonin, J PINEAL R, 27(4), 1999, pp. 226-229
Authors:
Pappolla, MA
Chyan, YJ
Bozner, P
Soto, C
Shao, H
Reiter, RJ
Brewer, G
Robakis, NK
Zagorski, MG
Frangione, B
Ghiso, J
Citation: Ma. Pappolla et al., Dual anti-amyloidogenic and antioxidant properties of melatonin: A new therapy for Alzheimer's disease?, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 661-669